Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 114401-114450 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT02543905
The PROFILE Study: Germline Genetic Profiling: Correlation With Targeted Prostate Cancer Screening and Treatment
N/A
Recruiting
1,600 participants
Started: Mar 9, 2015 · Completed: Dec 31, 2026
4 conditions
5 sponsors
1 location
NCT02361320
Computed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary Cancer
NA
Recruiting
259 participants
Started: Mar 9, 2015 · Completed: Jun 27, 2026
1 condition
2 sponsors
1 location
NCT02387905
Cement Augmentation in Preventing Vertebral Body Compression Fracture Following Spine Stereotactic Radiosurgery in Patients With Solid Tumors and Spinal Metastases
PHASE2
Active, not recruiting
87 participants
Started: Mar 9, 2015 · Completed: Dec 31, 2026
2 conditions
2 sponsors
1 location
NCT02381886
A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations
PHASE1
Active, not recruiting
166 participants
Started: Mar 6, 2015 · Completed: Feb 3, 2026
1 condition
1 sponsor
16 locations
NCT02386800
CINC424A2X01B Rollover Protocol
PHASE4
Active, not recruiting
279 participants
Started: Mar 5, 2015 · Completed: Sep 16, 2027
5 conditions
1 sponsor
98 locations
NCT02434393
Characterizing Cognitive Decline in Late Life Depression: The ADNI Depression Project
N/A
Recruiting
120 participants
Started: Mar 4, 2015 · Completed: May 31, 2027
2 conditions
4 sponsors
2 locations
NCT04792463
Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
N/A
Recruiting
500 participants
Started: Mar 3, 2015 · Completed: Jul 1, 2026
8 conditions
1 sponsor
1 location
NCT02389517
Lenalidomide With or Without Ixazomib Citrate and Dexamethasone in Treating Patients With Residual Multiple Myeloma After Donor Stem Cell Transplant
PHASE2
Active, not recruiting
42 participants
Started: Mar 2, 2015 · Completed: Mar 31, 2027
2 conditions
3 sponsors
1 location
NCT02213926
An Open-label, Phase 2 Study of ACP-196 (Acalabrutinib) in Subjects With Mantle Cell Lymphoma
PHASE2
Active, not recruiting
124 participants
Started: Mar 2, 2015 · Completed: Sep 6, 2026
1 condition
1 sponsor
58 locations
NCT02453542
Global Haemostatic Methods Following Administration of Bypassing Agents to Patients With Haemophilia With Inhibitors
N/A
Recruiting
20 participants
Started: Mar 1, 2015 · Completed: Aug 31, 2030
1 condition
1 sponsor
1 location
NCT02270567
RegisterNET - A Registry for Neuroendocrine Tumors in the USA
N/A
Enrolling by invitation
400 participants
Started: Feb 28, 2015 · Completed: Dec 31, 2025
3 conditions
1 sponsor
1 location
NCT02287311
Most Closely Matched 3rd Party Rapidly Generated LMP, BARF1 And EBNA1 Specific CTL, EBV-Positive Lymphoma (MABEL)
PHASE1
Active, not recruiting
38 participants
Started: Feb 28, 2015 · Completed: Mar 31, 2029
6 conditions
3 sponsors
2 locations
NCT02203643
Evaluation of the Safety and the Efficacy of Carfilzomib Combined With Cyclophosphamide and Dexamethasone (CCyd) or Lenalidomide and Dex (CRd) Followed by ASCT or 12 Cycles of Carf Combined With Dex and Len for Patients Eligible for ASCT With Newly Diagnosed Multiple Myeloma.
PHASE2
Active, not recruiting
477 participants
Started: Feb 28, 2015 · Completed: Mar 26, 2026
1 condition
1 sponsor
1 location
NCT02603679
Neoadjuvant Response-guided Treatment of Luminal B-type Tumors and Luminal A-type Tumors With Node Metastases
PHASE2
Active, not recruiting
181 participants
Started: Feb 28, 2015 · Completed: Dec 31, 2031
2 conditions
1 sponsor
3 locations
NCT02318732
Evaluation of California's Armed and Prohibited Persons System
NA
Active, not recruiting
20,000 participants
Started: Feb 28, 2015 · Completed: Jun 21, 2025
1 condition
4 sponsors
1 location
NCT02381353
Exparel Injection for Postoperative Orbital Pain
PHASE4
Recruiting
88 participants
Started: Feb 28, 2015 · Completed: Dec 31, 2026
1 condition
1 sponsor
2 locations
NCT02438631
Placental Passage and Disposition of Drugs: A Physiology-based Approach
N/A
Recruiting
2,000 participants
Started: Feb 28, 2015 · Completed: Dec 31, 2028
1 condition
5 sponsors
1 location
NCT02323399
Study to Determine the Pharmacokinetics and Pharmacodynamic Effects of Phenylephrine on BP Via IV
PHASE4
Recruiting
100 participants
Started: Feb 28, 2015 · Completed: Dec 31, 2024
1 condition
1 sponsor
10 locations
NCT02339064
Infusion of Apomorphine: Long-term Safety Study
PHASE3
Active, not recruiting
99 participants
Started: Feb 28, 2015 · Completed: Dec 31, 2025
1 condition
1 sponsor
18 locations
NCT02240862
The CREST-2 Registry
N/A
Recruiting
8,000 participants
Started: Feb 28, 2015 · Completed: Jan 31, 2026
1 condition
6 sponsors
1 location
NCT02065362
TGF-beta Resistant Cytotoxic T-lymphocytes in Treatment of EBV-positive Nasopharyngeal Carcinoma / RESIST-NPC
PHASE1
Active, not recruiting
14 participants
Started: Feb 28, 2015 · Completed: Feb 28, 2033
1 condition
4 sponsors
1 location
NCT02375841
Coping With Glioblastoma: A Study of Communication Between Physicians, Patients, and Caregivers
N/A
Active, not recruiting
309 participants
Started: Feb 28, 2015 · Completed: Feb 28, 2026
2 conditions
2 sponsors
8 locations
NCT02381301
Biomarkers and Cardiac CT
N/A
Recruiting
5,000 participants
Started: Feb 28, 2015 · Completed: Dec 31, 2029
2 conditions
1 sponsor
1 location
NCT04039945
Fr1da Early Diagnosis and Care of Type 1 Diabetes
N/A
Recruiting
285,000 participants
Started: Feb 28, 2015 · Completed: Dec 31, 2028
1 condition
1 sponsor
1 location
NCT02870244
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
PHASE1
Recruiting
18 participants
Started: Feb 28, 2015 · Completed: Sep 30, 2028
1 condition
2 sponsors
1 location
NCT02852538
Outcomes of a Skill-Based Program for Eating Disorders
NA
Enrolling by invitation
200 participants
Started: Feb 28, 2015 · Completed: Jan 31, 2027
1 condition
2 sponsors
2 locations
NCT02294435
Visceral Manifold and Unitary Device Study for the Repair of Thoracoabdominal Aortic Aneurysms
NA
Active, not recruiting
250 participants
Started: Feb 28, 2015 · Completed: Dec 31, 2029
1 condition
2 sponsors
1 location
NCT02371135
Metagenomic Evaluation of the Gut Microbiome in Patients With Lynch Syndrome and Other Hereditary Colonic Polyposis Syndromes
N/A
Active, not recruiting
77 participants
Started: Feb 28, 2015 · Completed: Feb 28, 2026
2 conditions
3 sponsors
1 location
NCT02369003
Cont. of a Study to Evaluate Implanting Peripheral Nerve Grafts Into Subjects With Parkinson's Disease (PD) During DBS
PHASE1
Active, not recruiting
70 participants
Started: Feb 28, 2015 · Completed: Sep 30, 2027
1 condition
1 sponsor
1 location
NCT02387736
DBT for Chronically Self-harming Individuals With BPD: Evaluating the Clinical & Cost Effectiveness of a 6 mo. Treatment
NA
Active, not recruiting
240 participants
Started: Feb 28, 2015 · Completed: Mar 31, 2025
1 condition
3 sponsors
2 locations
NCT02340676
A Phase II Trial of Low-Dose Interleukin-2 (IL-2) Added to Extra-Corporeal Photopheresis for Steroid-Refractory cGVHD
PHASE2
Active, not recruiting
25 participants
Started: Feb 28, 2015 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT02407808
Cannabinoids, Learning, and Memory
PHASE1
Active, not recruiting
80 participants
Started: Feb 28, 2015 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT02370797
Node Negative, Invasive Breast Cancer Single Fraction IOERT
NA
Active, not recruiting
100 participants
Started: Feb 28, 2015 · Completed: May 31, 2029
1 condition
1 sponsor
1 location
NCT02678182
Planning Treatment for Oesophago-gastric Cancer: a Maintenance Therapy Trial
PHASE2
Active, not recruiting
494 participants
Started: Feb 28, 2015 · Completed: Jun 30, 2027
3 conditions
5 sponsors
1 location
NCT02884284
Prospective and Retrospective Breast Cancer Database
N/A
Recruiting
10,000 participants
Started: Feb 28, 2015 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT02297672
Partial Breast Irradiation Using Interstitial Permanent Palladium-103 Seed Implant
NA
Active, not recruiting
75 participants
Started: Feb 28, 2015 · Completed: Feb 28, 2026
1 condition
1 sponsor
1 location
NCT02346747
A Trial of Vigil for Participants With Ovarian Cancer
PHASE2
Active, not recruiting
92 participants
Started: Feb 28, 2015 · Completed: Dec 31, 2025
2 conditions
1 sponsor
26 locations
NCT02365090
Binocular iPad Sub-Study
NA
Active, not recruiting
96 participants
Started: Feb 28, 2015 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT03022682
Inflammation, Diabetes, Ethnicity and Obesity Cohort
N/A
Recruiting
350 participants
Started: Feb 28, 2015 · Completed: Dec 31, 2026
3 conditions
1 sponsor
1 location
NCT02919930
Interface Selection for Adaptive Servo Ventilation
NA
Recruiting
15 participants
Started: Feb 28, 2015 · Completed: Jan 31, 2025
2 conditions
1 sponsor
1 location
NCT02157025
A More Engaging Visual Field Test to Increase Use and Reliability in Pediatrics
NA
Recruiting
20 participants
Started: Feb 28, 2015 · Completed: Dec 31, 2027
4 conditions
1 sponsor
1 location
NCT02316379
Use of Hyperpolarized 129Xe MR Lung Imaging in Adults for Calibration
PHASE1/PHASE2
Recruiting
100 participants
Started: Feb 28, 2015 · Completed: Aug 24, 2031
1 condition
1 sponsor
1 location
NCT03531658
Singapore PREconception Study of Long-Term Maternal and Child Outcomes
N/A
Active, not recruiting
1,054 participants
Started: Feb 27, 2015 · Completed: Dec 31, 2029
7 conditions
3 sponsors
1 location
NCT01209871
Vaccine Therapy in Treating Patients With Lymphoplasmacytic Lymphoma
PHASE1
Active, not recruiting
9 participants
Started: Feb 26, 2015 · Completed: Feb 20, 2026
1 condition
2 sponsors
1 location
NCT02122185
Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
PHASE2
Active, not recruiting
110 participants
Started: Feb 25, 2015 · Completed: Feb 25, 2027
28 conditions
1 sponsor
10 locations
NCT02315196
Pegylated Liposomal Doxorubicin Hydrochloride and Carboplatin Followed by Surgery and Paclitaxel in Treating Patients With Triple Negative Stage II-III Breast Cancer
PHASE2
Active, not recruiting
62 participants
Started: Feb 25, 2015 · Completed: Jul 31, 2041
9 conditions
3 sponsors
1 location
NCT01896479
A Study of Two Different Doses of Cabozantinib (XL184) in Progressive, Metastatic Medullary Thyroid Cancer
PHASE4
Active, not recruiting
247 participants
Started: Feb 25, 2015 · Completed: Jan 31, 2035
1 condition
1 sponsor
49 locations
NCT02273375
Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC
PHASE3
Active, not recruiting
1,415 participants
Started: Feb 24, 2015 · Completed: Jan 31, 2026
1 condition
11 sponsors
271 locations
NCT06193850
Protocol N. 2014 - Observational Study on the Quality of Life of Outpatients
N/A
Recruiting
10,000 participants
Started: Feb 24, 2015 · Completed: Jan 31, 2045
3 conditions
1 sponsor
1 location
NCT02362503
Attachment Inhibitor Comparison in Heavily Treatment Experienced Patients
PHASE3
Active, not recruiting
371 participants
Started: Feb 23, 2015 · Completed: Sep 30, 2026
1 condition
1 sponsor
139 locations
Previous
1
More pages
2286
2287
2288
2289
2290
2291
2292
More pages
2369
Next